Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors
This study has been completed.
Study NCT00495144   Information provided by Threshold Pharmaceuticals

First Received on June 28, 2007.   Last Updated on July 25, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tumors
Hypoxia
Additional conditions recognized in this trial
Anoxia
More general conditions related to this trial
Signs and Symptoms
Signs and Symptoms, Respiratory
Interventions listed in this trial
TH-302
Sponsors listed in this trial
Threshold Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services